Vera Therapeutics, Incorporated develops treatments for patients with serious immunological diseases in the U.S. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy. It is also developing MAU868, a monoclonal antibody for the treatment of BK viremia infections and is under Phase 2 clinical trial. Known as Trucode Gene Repair, Inc. until 2020, Vera Therapeutics was incorporated in 2016 and is headquartered in Brisbane, CA.
What is Vera Therapeutics's quote symbol?
What is the 52 week high and low for Vera Therapeutics (NASDAQ: VERA)?
How much is Vera Therapeutics stock worth today?
How much is Vera Therapeutics's stock price per share?
What is Vera Therapeutics's Market Cap?